Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Macromoltek

Macromoltek?uq=w9if130k
2010 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE (Announced)
$500K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a molecular modeling software designed to analyze potential antibody drug candidates. The company's software uses proprietary algorithms to optimize the selection process, solves antibody structures computationally, offers online workspace and more, enabling help researchers make new discoveries by keeping the focus on their science.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Other Software
Primary Office
  • 2500 West William Cannon Drive
  • Suite 204
  • Austin, TX 78745
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Macromoltek’s full profile, request a free trial.

Macromoltek Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Angel (individual) $500K 00000 Announced Startup
5. Accelerator/Incubator 19-Mar-2018 00000 00000 00.000 Completed Startup
4. Grant 20-Aug-2016 00000 Completed Startup
3. Accelerator/Incubator 01-Mar-2015 Completed Startup
2. Grant 01-Jan-2015 $150K Completed Startup
1. Accelerator/Incubator 10-Dec-2014 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Macromoltek Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Y Combinator Accelerator/Incubator Minority 000 0000 000000 0
Capital Factory Accelerator/Incubator Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Texas Venture Labs Accelerator/Incubator 000 0000 000000 0

Macromoltek Executive Team (2)

Name Title Board
Seat
Contact
Info
Monica Berrondo Co-Founder & Chief Executive Officer
Susana Kaufmann Co-Founder & Chief Financial Officer